Characterization of in vivo expanded OspA-specific human T-cell clones

Geahča maid

• Characterization of in vivo expanded OspA-specific human T-cell clones.
  Dahkki: Ausubel, L, et al.
  Almmustuhtton: (2005)
• The year that shaped the outcome of the OspA vaccine for human Lyme disease
  Dahkki: Raymond J. Dattwyler, et al.
  Almmustuhtton: (2022-01-01)
• OspA heterogeneity of <it>Borrelia valaisiana </it>confirmed by phenotypic and genotypic analyses
  Dahkki: Bretz Anne-Gabrielle, et al.
  Almmustuhtton: (2003-06-01)
• Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters
  Dahkki: Deborah A Grosenbaugh, et al.
  Almmustuhtton: (2018-10-01)
• The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes.
  Dahkki: Pär Comstedt, et al.
  Almmustuhtton: (2017-01-01)